Replimune: Acceptance Confirms Completeness, Not Approval (Rating Upgrade)
Source: SeekingAlpha
2025-10-21 07:30:16 ET
Replimune Overview
Replimune ( REPL ) has been on quite the ride since my latest Sell rating in July 2025....
Read the full article on Seeking Alpha
For further details see:
Replimune: Acceptance Confirms Completeness, Not Approval (Rating Upgrade)
Replimune Group Inc.
NASDAQ: REPL
REPL Trading
-7.29% G/L:
$7.89 Last:
677,115 Volume:
$8.18 Open:
REPL Latest News
February 03, 2026 08:00:00 am
Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
December 18, 2025 08:00:00 am
Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference
REPL Stock Data
$646,543,607
51,607,887
0.33%
61
N/A
Biotechnology & Life Sciences
Healthcare
US
Woburn
